Table 3 Yearly prevalence of selected markers
YEAR | Both rounds | 2016 | 2017 | p-value (z test) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
n/N | % | 95% CI | n/N | % | 95% CI | n/N | % | 95% CI | ||
pfk13 K189T | 190/349 | 54.4% | 49.2–59.6% | 86/157 | 54.8% | 47.0–62.4% | 104/192 | 54.2% | 47.1–61.1% | 0.909 |
pfmdr1 + pfcrt NFD + K | 172/331 | 52.0% | 46.4–57.5% | 77/147 | 53.1% | 44.3–60.3% | 95/184 | 51.1% | 44.5–58.7% | 0.892 |
pfdhfr IRN | 285/336 | 84.8% | 80.5–88.5% | 127/149 | 85.2% | 78.7–90.0% | 158/187 | 84.5% | 78.6–89.0% | 0.850 |